Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/19/2022
Pfizer Signs China Partnership to Make Paxlovid Covid Pills Locally
8/17/2022
WuXi STA Breaks Ground for 2nd Drug Manufacturing Facility in the U.S.
7/21/2022
WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapor...
7/19/2022
WuXi STA Opens a New Large Scale Continuous Manufacturing Plant
7/19/2022
WuXi AppTec Plans to Build a New Site in Singapore with Planned S$2B I...
7/14/2022
CStone Considers Sale Amid Mounting Challenges: Bloomberg
7/7/2022
Pharmaron Acquires Commercial API Manufacturing Facility in the U.S.
7/1/2022
Eurofins DiscoverX Establishes A New China Biotechnology Office
6/29/2022
WuXi STA Opens Another High-Potency API Plant In Changzhou
6/23/2022
GlobalData: Borrena (lorlatinib) Approval Further Strengthens Pfizer P...
6/7/2022
CanSino and Pfizer Terminate vaccine deal
6/6/2022
WuXi Biologics Launches First Commercial Drug Product Facility for Pre...
6/3/2022
NeoGenomics's Suzhou Pharma Services Lab Gets CAP Certification
5/24/2022
Vir and WuXi Bio Terminate COVID Antibody Agreement
5/23/2022
Fujifilm Completes Construction of Bioprocessing Innovation & Collabor...
5/23/2022
Biopharma in China: The Emerging Global Force of Domestic Suppliers
5/2/2022
Pfizer Wins Chinese Approval of lorlatinib for ALK-positive Advanced N...
4/28/2022
Stevanato Group Acquires Manufacturing Facility in Zhejiang to Suppor...
4/18/2022
VectorBuilder to Build $500M Gene Therapy Manufacturing Facility in Ch...
4/12/2022
Pfizer Wins Chinese Approval of JAK1 Inhibitor Abrocitinib for moderat...
4/11/2022
Decentralized CRO Science 37 Expands in the Asia-Pacific including Chi...
4/7/2022
The Chinese Pharma CMO Market to Reach $13B in 2030, Predicts Roots An...
4/7/2022
CDMO Asymchem Completes Expansion of Chinese Manufactuing Facilitie...
3/24/2022
Fosun Reports Over CNY 1B of BioNTech mRNA Vaccine Sales in 2021 Despi...
3/17/2022
Five Chinese Firms Agree to Make Generic Version of Pfizer's Oral COVI...
3/16/2022
Pfizer COVID-19 Pill Added to Pandemic Treatment Guidelines in China ...
3/11/2022
Pharma CMO Stevanato Group Expands Capacity in China with New Facility
3/9/2022
Lonza Expands API Development and Manufacturing Laboratories in Nansha
3/9/2022
China Meheco Inks Deal to Market Pfizer's Covid Pill Paxlovid in China
3/3/2022
WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at ...
Page:
5
/
26
Total number of articles:
777
:
[First]
[<<]
[3]
[4]
[5]
[6]
[7]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit